Close encounters of a novel kind: a multi-targeted cancer drug meets a metabolic sensor.
Billaud
Marc
M
CNRS UMR 5201, Laboratoire Génétique Moléculaire Signalisation et Cancer, Université de Lyon 1, Centre Léon Bérard, Lyon, France. billaud@lyon.fnclcc.fr
Viollet
Benoît
B
D055372:AMP-Activated Protein Kinases / Q000037:antagonists & inhibitors* / Q000502:physiology*; D020533:Angiogenesis Inhibitors / Q000494:pharmacology*; D000818:Animals; D006801:Humans; D007211:Indoles / Q000494:pharmacology*; D009369:Neoplasms / Q000188:drug therapy* / Q000201:enzymology; D011758:Pyrroles / Q000494:pharmacology*; D000077210:Sunitinib
D020533:Angiogenesis Inhibitors; D007211:Indoles; D011758:Pyrroles; D055372:AMP-Activated Protein Kinases; D000077210:Sunitinib